Evgeny Barinov, Deputy CEO of Finance and Digital Technology, and Artem An, Director of Strategic Business Development, took part in the three-day WHO SAGE (Strategic Advisory Group of Experts) session on immunization in Geneva.

This annual session brings together representatives of the WHO, UNICEF, GAVI, regional regulatory authorities, vaccine research community and vaccine manufacturers with the aim of summing up the year’s results on the immunization status in 180+ countries, discussing the effectiveness of certain vaccines, and presenting an action plan for the future years.

At the current session, special attention was paid to vaccination to prevent such infections as measles, rubella, human papillomavirus (HPV), Ebola and polio. It is for these diseases that concern of the global community has remained very high in recent years, and the WHO is making a serious effort to overcome all the difficulties over the next decade.

The SAGE session meeting agenda was quite packed. Artem and Evgeny introduced NANOLEK as a key player in the Russian domestic vaccine market, and discussed joint UNICEF collaboration plans with respect to inactivated polio vaccine (IPV) and HPV vaccine.

Evgeny Barinov: “NANOLEK took part in the SAGE session for the first time, and this underscores the importance of the current stage in the company development. In the future, while developing and manufacturing its own vaccines, NANOLEK would like to partner with UNICEF for their supply. The course of the meetings has shown that the WHO representatives are ready to seriously consider us as a potential approved supplier. There is still a huge amount of work ahead, but a successful start has been made.”

Artem An: “The battle against serious infections and viruses threatening human life and well-being cannot be merely a local goal. This is a global topic, and we want to be the obvious answer to the needs and requirements of the international community for effective immunization.”